Open AccessTreatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Author(s) -
Jane R. Schwebke,
Shelly Lensing,
Jeannette Lee,
Christina A Muzny,
Angela Pontius,
Nicole Woznicki,
Tina Aguin,
Jack D. Sobel
Publication year - 2020
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1903
Subject(s) - medicine , metronidazole , bacterial vaginosis , placebo , clinical endpoint , randomized controlled trial , population , gynecology , antibiotics , alternative medicine , environmental health , pathology , microbiology and biotechnology , biology
We aimed to determine if treatment of male sexual partners of women with recurrent bacterial vaginosis (BV) with oral metronidazole 2×/day for 7 days (ie, multidose metronidazole) significantly decreased BV recurrence rates in the female.